Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
Nan, Fang‐yu, Gu, Yu, Xu, Zi‐jun, Sun, Guo‐kang, Zhou, Jing‐dong, Zhang, Ting‐juan, Ma, Ji‐chun, Leng, Jia‐yan, Lin, Jiang, Qian, Jun
Published in Cancer medicine (Malden, MA) (01.08.2021)
Published in Cancer medicine (Malden, MA) (01.08.2021)
Get full text
Journal Article
DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia
Sun, Guo‐Kang, Tang, Li‐Juan, Zhou, Jing‐Dong, Xu, Zi‐Jun, Yang, Lan, Yuan, Qian, Ma, Ji‐Chun, Liu, Xing‐Hui, Lin, Jiang, Qian, Jun, Yao, Dong‐Ming
Published in Cancer medicine (Malden, MA) (01.10.2019)
Published in Cancer medicine (Malden, MA) (01.10.2019)
Get full text
Journal Article
Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine
Tang, Li-Juan, Sun, Guo-Kang, Zhang, Ting-Juan, Wu, De-Hong, Zhou, Jing-Dong, Ma, Bei-Bei, Xu, Zi-Jun, Wen, Xiang-Mei, Chen, Qin, Yao, Dong-Ming, Qian, Jun, Ma, Ji-Chun, Lin, Jiang
Published in Cancer cell international (10.07.2019)
Published in Cancer cell international (10.07.2019)
Get full text
Journal Article